Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is designed for patients with symptomatic moderate-to-severe or severe MR
Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
Subscribe To Our Newsletter & Stay Updated
